Osimertinib in patients with EGFR-mutated NSCLC and leptomeningeal or brain metastases: Results of the IFCT-1804 ORBITAL trial

Etude concernée: IFCT-1804
Auteurs / Authors: D. Planchard, A.C. Toffart, A.C. Madroszyk, M. Wislez, S. Martinez, I. Monnet, S. Hiret, V. Gounant, A.C. Métivier, C. Domblides , E. Giroux-Leprieur, E. Huchot, P. Tomasini, C. Mascaux, D. Carmier, A. Langlais, F. Morin, V. Westeel, A. Cortot
Journal / Conference: ESMO
Année / Year: 2023
PMID: Poster session
Lien vers la publication: https://www.ifct.fr/images/IFCT-1804_poster_v1.0_20231012.pdf